Riskpilot← Back to searchSign inGet full accessSAGA Diagnostics AB
ABActiveOrg 5590503305Scheelevägen 2 Mv-406Research and experimental development on natural sciences and engineering · NACE 7210Est. 201610-19 employees
Revenue 2025
SEK 831K
+139% vs 2024
EBITDA margin
-4743.6%
+14% vs 2024
Equity ratio
93.9%
Financial strength
Net profit 2025
SEK -38,1M
+10% vs 2024
| Revenue | SEK 831K | +139% |
| EBITDA | SEK -39,4M | +14% |
| Net profit | SEK -38,1M | +10% |
| Total assets | SEK 98,1M | -29% |
| Equity | SEK 92,1M | -29% |
| Employees | — | — |
Legal name
SAGA Diagnostics AB
Org number
5590503305
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
5 februari 2016
Share capital
SEK 168 184
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva verksamhet inom biomedicinsk diagnostik och annan teknik och omfattar utveckling, licensiering, utbildning, marknadsföring, distribution och försäljning av biomedicinsk diagnostik och biovetenskapliga metoder, teknik, reagenser, produkter, instrument och laboratorietjänster. En särskild inriktning på företaget är kroppsvätskebaserade diagnostiska biomarkörer i onkologi samt i andra sjukdomstillstånd, samt därmed förenlig verksamhet.
Address
Scheelevägen 2 Mv-406
Email
info@sagadiagnostics.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 324 | 533 | 2 438 | 3 429 | 2 350 | 4 983 | 2 136 | 347 | 831 |
| Staff expenses | — | — | — | — | — | — | — | — | — | −23 804 |
| EBITDA | −232 | −22 | −2 374 | −10 332 | −18 648 | −26 482 | −26 267 | −40 937 | −45 610 | −39 405 |
| Depreciation & amort. | −0 | −0 | −48 | −104 | −108 | −108 | −175 | −147 | −295 | −0 |
| EBIT | −232 | −22 | −2 422 | −10 436 | −18 756 | −26 590 | −26 442 | −41 084 | −45 905 | −39 717 |
| Net financials | — | — | −8 | −15 | −14 | −36 | −57 | 1 486 | 3 727 | 1 588 |
| Profit before tax | −232 | −22 | −2 430 | −10 450 | −18 771 | −26 625 | −26 499 | −39 597 | −42 179 | −38 129 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −232 | −22 | −2 430 | −10 450 | −18 771 | −26 625 | −26 499 | −39 597 | −42 179 | −38 129 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 510 | 342 | 10 337 | 15 620 | 10 808 | 101 437 | 72 245 | 185 850 | 138 562 | 98 109 |
| Equity | 312 | 309 | 9 107 | 13 112 | 6 648 | 94 234 | 67 736 | 172 394 | 130 215 | 92 087 |
| Long-term debt | 0 | 0 | 205 | 157 | 107 | 26 | 0 | 0 | 0 | 0 |
| Short-term debt | 198 | 34 | 1 025 | 2 352 | 4 053 | 7 178 | 4 510 | 13 456 | 8 347 | 6 022 |
| Total debt | 198 | 34 | 1 230 | 2 509 | 4 160 | 7 204 | 4 510 | 13 456 | 8 347 | 6 022 |
EBITDA margin
-4743.6%
This company
15.8%
Market median
-30123% vs market
20162025
Equity ratio
93.9%
This company
38.2%
Market median
+146% vs market
20162025
Return on equity
-41.4%
This company
18.4%
Market median
-325% vs market
20162025
Net profit margin
-4590.0%
This company
8.1%
Market median
-56767% vs market
20162025
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20162025
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-02-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PM Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
KM Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
MS Chief Auditor | Chief Auditor | 2021 | — | — |
LH Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Chairman | 2022 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2021 | — | — | |
| Chairman | 2025 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SAGA Diagnostics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Michael Collins | Chief Executive Officer | 0 companies |
| Karolina Maria Holm | Chief Executive Officer | 0 companies |
| Maria Sofia Ekelund | Chief Auditor | 0 companies |
| Lao Hayamizu Saal | Deputy Chief Executive Officer | 0 companies |
| Henrik Winther | Board of Directors | 0 companies |
| Karin Marie Christine Widstrand | Deputy Board Member | 0 companies |
| Sirshendu Roopom Banerjee | Chairman | 0 companies |
| James Roger Gunnarsson | Chairman | 0 companies |
| Brian Buchanan Dow | Board of Directors | 0 companies |
| Derek Gregory Batcheller | Chairman | 0 companies |
| Batcheller,Derek Gregory | Chairman | 0 companies |
| Sofia Katarina Gruvberger Saal | Deputy Board Member | 0 companies |
| Anthony Miles George | Deputy Board Member | 0 companies |
| Ernst Lennart Westman | Board of Directors | 0 companies |
| Walter Stockinger | Board of Directors | 0 companies |
| Mia Johanna Olså | Deputy Board Member | 0 companies |
| Rolf Bertil Ehrnström | Board of Directors | 0 companies |
| Roger James Franklin | Deputy Board Member | 0 companies |